Walgreens' cost-cut plans aim to save more than $1 billion annually
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
JPMorgan Reiterates Neutral on Rite Aid (RAD) Following 3Q Report
December 21, 2018 7:25 AM ESTJPMorgan analyst, Lisa Gill, reiterated a Neutral rating on Rite-Aid (NYSE: RAD) following the company's 3Q earnings report. Adjusted EBITDA was $13M above forecasts, with upside driven mainly on the gross profit line. Adjusted EPS of +$0.01 compared to estimates of -$0.01.
In the retail... More
Walgreens Boosts Alliance (WBA) PT Lowered to $95 at Credit Suisse
December 21, 2018 7:03 AM ESTCredit Suisse analyst Erin Wilson Wright lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $95.00 (from $97.00) while maintaining a Outperform rating following Q1 results.
The analyst notes while the company reaffirmed 2019 constant-currency EPS growth of +7-12%, they are lowering FY19 EPS... More
